-
1
-
-
55749092073
-
-
ICH Guidance on Specifications:, October, Federal Register, December 29
-
ICH Guidance on Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances Q6A, October 1999. (Federal Register, Vol.65, No. 251, Pages 83041-83063, December 29, 2000).
-
(1999)
Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances Q6A
, vol.65
, Issue.251
, pp. 83041-83063
-
-
-
3
-
-
0004103366
-
-
Drugs and the Pharmaceutical Sciences, CRC Press, ISBN: 0824785673, Marcel Dekker, New York, NY 1991
-
Umesh V. Banakar, "Pharmaceutical Dissolution Testing", Drugs and the Pharmaceutical Sciences, Vol. 49, CRC Press, ISBN: 0824785673, Marcel Dekker, New York, NY (1991).
-
Pharmaceutical Dissolution Testing
, vol.49
-
-
Banakar, U.V.1
-
4
-
-
0038283006
-
Once-a Day Controlled -Released Dosage Form of Divalproex Sodium I: Formulation Design and In Vitro/In Vivo Investigation
-
Qiu, Yihong; Cheskin, Howard S.; Engh, Kevin R.; Poska, Richard P. "Once-a Day Controlled -Released Dosage Form of Divalproex Sodium I: Formulation Design and In Vitro/In Vivo Investigation", J. of Pharmarceutical Sciences, Vol. 92(6), Pages 1166-1173, (2003).
-
(2003)
J. of Pharmarceutical Sciences
, vol.92
, Issue.6
, pp. 1166-1173
-
-
Qiu, Y.1
Cheskin, H.S.2
Engh, K.R.3
Poska, R.P.4
-
5
-
-
0242353396
-
-
Qiu, Yihong; Garren, J.; Samara, E.; Cao, G.; Abraham, C. Cheskin, H. S.; Engh, K. R. Once-a Day Controlled -Released Dosage Form of Divalproex Sodium II: Development of a Predictive In Vitro Drug Release Method , J. of Pharmarceutical Sciences, 92(11), Pages 2317-2325, (2003).
-
Qiu, Yihong; Garren, J.; Samara, E.; Cao, G.; Abraham, C. Cheskin, H. S.; Engh, K. R. "Once-a Day Controlled -Released Dosage Form of Divalproex Sodium II: Development of a Predictive In Vitro Drug Release Method ", J. of Pharmarceutical Sciences, Vol. 92(11), Pages 2317-2325, (2003).
-
-
-
-
6
-
-
0029852535
-
Overview of Workshop: In Vitro Dissolution of Immediate Release Dosage Forms: Development of In Vivo Relevance and Quality Control Issues
-
Iain J. McGilveray, "Overview of Workshop: In Vitro Dissolution of Immediate Release Dosage Forms: Development of In Vivo Relevance and Quality Control Issues", Drug Information Journal, Vol. 30, Pages 1029-1037, (1996).
-
(1996)
Drug Information Journal
, vol.30
, pp. 1029-1037
-
-
McGilveray, I.J.1
-
7
-
-
55749086769
-
-
ICH Guidance on Quality Risk Management Q9, November 2005. (Federal Register, 70, No. 151; pages 45722-45723, August 8, 2005).
-
ICH Guidance on Quality Risk Management Q9, November 2005. (Federal Register, Vol. 70, No. 151; pages 45722-45723, August 8, 2005).
-
-
-
-
8
-
-
33746646361
-
Pepsin and Pancreatin Performance in the Dissolution of Crosslinked Gelatin Capsules from pH 1 to 8
-
Jean Gallery, Jian-Hwa Han, and Chiramel Abraham "Pepsin and Pancreatin Performance in the Dissolution of Crosslinked Gelatin Capsules from pH 1 to 8", Pharmacopeial Forum, Vol. 30(3), Pages 1084-1089, (2004).
-
(2004)
Pharmacopeial Forum
, vol.30
, Issue.3
, pp. 1084-1089
-
-
Gallery, J.1
Han, J.-H.2
Abraham, C.3
-
9
-
-
55749101305
-
-
USP 29-NF 24, 〈711〉 Dissolution, (2006).
-
USP 29-NF 24, 〈711〉 Dissolution, (2006).
-
-
-
-
10
-
-
0000733346
-
Stimuli to the Revision Process: "Collaborative Development of Two-Tiered Dissolution Testing for Gelatin Capsules and Gelatin-Coated Tablets using Enzyme- Containing Media
-
Gelatin Capsule Working Group
-
Gelatin Capsule Working Group, Stimuli to the Revision Process: "Collaborative Development of Two-Tiered Dissolution Testing for Gelatin Capsules and Gelatin-Coated Tablets using Enzyme- Containing Media", Pharmacopeial Forum 24 (5): 7045-7050 (1998).
-
(1998)
Pharmacopeial Forum
, vol.24
, Issue.5
, pp. 7045-7050
-
-
|